BIO 300 will be the subject of a presentation at a U.S. industry, national security, and healthcare forum on February 27th, 2025.
Oragenics, Inc. (NYSE American: OGEN), a biotechnology company advancing innovative treatments for concussion and ...
"When I was navigating going into the field of medicine there weren't a lot of people who looked like me and that makes it challenging so I wanted to be able to be that representation for them that I ...
Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...